Condensed Consolidated Statements of Cash Flows (USD $) In Millions, unless otherwise specified	9 Months Ended
	Jun. 29, 2013	Jun. 30, 2012
Cash and cash equivalents, beginning of the period	$ 10,746	$ 9,815
Operating activities:
Net income	29,525	33,510
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization	4,974	2,296
Share-based compensation expense	1,698	1,292
Deferred income tax expense	2,524	4,066
Changes in operating assets and liabilities:
Accounts receivable, net	2,091	(2,278)
Inventories	(906)	(346)
Vendor non-trade receivables	3,148	(293)
Other current and non-current assets	484	(3,238)
Accounts payable	(4,740)	2,450
Deferred revenue	1,404	2,575
Other current and non-current liabilities	3,556	1,686
Cash generated by operating activities	43,758	41,720
Investing activities:
Purchases of marketable securities	(122,681)	(121,091)
Proceeds from maturities of marketable securities	13,963	10,344
Proceeds from sales of marketable securities	81,734	73,140
Payments made in connection with business acquisitions, net	(443)	(350)
Payments for acquisition of property, plant and equipment	(6,210)	(4,834)
Payments for acquisition of intangible assets	(560)	(1,067)
Other	(188)	(56)
Cash used in investing activities	(34,385)	(43,914)
Financing activities:
Proceeds from issuance of common stock	335	433
Excess tax benefits from equity awards	644	1,036
Taxes paid related to net share settlement of equity awards	(1,001)	(1,145)
Dividends and dividend equivalent rights paid	(7,795)	0
Repurchase of common stock	(17,950)	0
Proceeds from issuance of long-term debt, net	16,896	0
Cash (used in)/generated by financing activities	(8,871)	324
Increase/(decrease) in cash and cash equivalents	502	(1,870)
Cash and cash equivalents, end of the period	11,248	7,945
Supplemental cash flow disclosure:
Cash paid for income taxes, net	$ 7,188	$ 5,901